14th Annual Mayo Clinic Hematology Review 2017
Course Directors: Thomas M. Habermann, M.D. and Thomas E. Witzig, M.D.
This one-day educational program will provide hematology and oncology clinicians, nurse practitioners and physician assistants with an overview of the most recent advances in the treatment of various hematologic malignancies, based on abstracts presented at the December 2016 annual meeting of the American Society of Hematology (ASH). Invited speakers present exciting and relevant abstracts presented at the ASH meeting and discuss their clinical relevance to the hematology/oncology practice.
This course offers the unique opportunity for commercial companies to interact with health care providers and highlight their products and services. If you are interested in exhibit space during this course, please contact Jenna Pederson.
This course is designed for physicians, nurse practitioners, physician assistants, nurses and fellows in training.
Upon conclusion of this program, participants should be able to:
- Describe the results of important disease-specific clinical trials presented at the American Society of Hematology Annual Meeting in 2016 and put them into clinical context.
- Identify investigational therapeutic regimens that are available as alternatives to standard of care approaches.
- Compare with current clinical practice the advances in managing various hematological malignancies that were presented at the American Society of Hematology Annual Meeting.
Attendance at this Mayo course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.
- 7.25 AMA PRA Category 1 Credit™